Odile Carrette
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Odile Carrette has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Denis F. Hochstrasser
Biomedical Proteomics Research Group, Geneva University Hospital and Medical School, Geneva, Switzerland
2 shared publicationsPierre R. Burkhard
Department of Neurology, Geneva University Hospital and Medical School, Geneva, Switzerland
2 shared publicationsSeverine Hughes
Central Clinical Chemistry Laboratory, Geneva University Hospital and Medical School, Geneva, Switzerland
2 shared publicationsC. Lang
Department of Econometry, Geneva University, Geneva, Switzerland
1 shared publicationD.F. Hochstrasser
Biomedical Proteomics Research Group, Department of Structural Biology and Bioinformatics, Geneva University, Faculty of Medicine, Geneva, Switzerland
1 shared publicationJ.-C. Sanchez
Biomedical Proteomics Research Group, Department of Structural Biology and Bioinformatics, Geneva University, Faculty of Medicine, Geneva, Switzerland
1 shared publication
Latest Publications
- 7 August 2006
- Published by Elsevier in Journal of Chromatography B
- Vol. 840 (1) , 1-9
Changes of the cortex proteome and Apolipoprotein E in transgenic mouse models of Alzheimer's Disease
- 7 August 2006
- Published by Elsevier in Journal of Chromatography B
- Vol. 840 (1) , 1-9
Changes of the cortex proteome and Apolipoprotein E in transgenic mouse models of Alzheimer's Disease
- Open Access
- 16 September 2005
- Published by Wiley in Proteomics
- Vol. 5 (14) , 3822
Truncated cystatin C in cerebrospiral fluid: Technical artefact or biological process? (vol. 5, Issue 12, pp. 3060-3065)
See original http://dx.doi.org/10.1002/pmic.200402039
- 16 September 2005
- Published by Wiley in Proteomics
- Vol. 5 (14) , 3822
Open AccessTruncated cystatin C in cerebrospiral fluid: Technical artefact or biological process? (vol. 5, Issue 12, pp. 3060-3065)
See original http://dx.doi.org/10.1002/pmic.200402039
- 2 August 2005
- Published by Wiley in Proteomics
- Vol. 5 (12) , 3060-3065
Truncated cystatin C in cerebrospiral fluid: Technical artefact or biological process?
Cystatin C, a low molecular weight cysteine proteinase inhibitor present in human body fluids at physiological concentrations, is more expressed in cerebrospinal fluid (CSF) than in plasma. Mass spectrometric characterization showed that after 3 months of storage of human CSF at −;20°C, cystatin C was cleaved in the peptide bond between R8 and L9 and lost its eight N‐termini amino acids, whereas this cleavage did not occur when stored at −80°C. This truncation occurred in all CSF samples studied irrespective of the underlying neurological status, indicating a storage‐related artefact rather than a physiological or pathological processing of the protein. These results stress the importance of optimal preanalytical storage conditions of any sample prior to proteomics studies.
- 2 August 2005
- Published by Wiley in Proteomics
- Vol. 5 (12) , 3060-3065
Truncated cystatin C in cerebrospiral fluid: Technical artefact or biological process?
Cystatin C, a low molecular weight cysteine proteinase inhibitor present in human body fluids at physiological concentrations, is more expressed in cerebrospinal fluid (CSF) than in plasma. Mass spectrometric characterization showed that after 3 months of storage of human CSF at −;20°C, cystatin C was cleaved in the peptide bond between R8 and L9 and lost its eight N‐termini amino acids, whereas this cleavage did not occur when stored at −80°C. This truncation occurred in all CSF samples studied irrespective of the underlying neurological status, indicating a storage‐related artefact rather than a physiological or pathological processing of the protein. These results stress the importance of optimal preanalytical storage conditions of any sample prior to proteomics studies.